Filbrandt Wealth Management’s Gilead Sciences GILD Stock Holding History

Filbrandt Wealth Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$68K	Buy	977 +20	+2%	+$1.41K	0.04%	74
2021 Q2	$66K	Buy	957 +3	+0.3%	+$200	0.04%	79
2021 Q1	$62K	Buy	954 +154	+19%	+$9.93K	0.04%	79
2020 Q4	$47K	Hold	800	–	–	0.03%	88
2020 Q3	$51K	Sell	800 -126	-14%	-$8.74K	0.04%	82
2020 Q2	$71K	Buy	926 +126	+16%	+$9.66K	0.06%	91
2020 Q1	$60K	Hold	800	–	–	0.07%	59
2019 Q4	$51K	Buy	+800	New	+$52.1K	0.05%	81

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Filbrandt Wealth Management's GILD Position: Q3 2021 in Review

Filbrandt Wealth Management increased its Gilead Sciences (GILD) stake by 2.1% in Q3 2021, buying an estimated $1.41K and bringing the position to 977 shares worth $68K. The position accounts for 0.04% of the portfolio, ranked #74.

Filbrandt Wealth Management first reported a position in GILD in Q4 2019 and has held it in 8 quarters since. The position peaked at $71K in Q2 2020. 1,563 funds tracked by Wall St. Rank hold GILD as of Q3 2021.

Filbrandt Wealth Management held 977 shares of Gilead Sciences worth $68K as of Q3 2021.
Filbrandt Wealth Management bought 20 Gilead Sciences shares in Q3 2021, an estimated $1.41K.
Gilead Sciences made up 0.04% of Filbrandt Wealth Management's portfolio in Q3 2021, its #74 holding.
Filbrandt Wealth Management first reported a position in Gilead Sciences in Q4 2019 and has held it in 8 quarters since.
Filbrandt Wealth Management's Gilead Sciences position peaked at $71K in Q2 2020.
1,563 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2021.

Based on Filbrandt Wealth Management's 13F filing for Q3 2021, filed 6 Oct 2021.